Your session is about to expire
← Back to Search
Belbuca Buccal Product for Depression
Study Summary
This trial will test if adding low-dose buprenorphine to standard depression treatment can reduce suicidal thoughts by studying brain activity.
- Depression
- Suicidal Thoughts
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are Belbuca Buccal Product's known side effects?
"Belbuca Buccal Product's safety is rated at a 3."
How many subjects are involved in this experiment?
"The clinical trial is currently recruiting participants, with 30 patients needed from 1 location. Information on the study was first posted on 10/10/2022 and updated on 10/24/2022."
Which type of patient is most likely to respond well to this treatment?
"Suicidal ideation is a primary criteria for being accepted into this trial. The age requirement is between 18 and 65 years old. There are only 30 spots available in total."
Does this research require that participants be of a certain age?
"As specified in the eligibility requirements, adults aged 18 to 65 are able to enroll in this particular clinical trial."
Are there any available positions for volunteers in this clinical trial?
"The listing for this clinical trial on clinicaltrials.gov says that the research team is currently looking for participants. The study was first announced on October 10th, 2020 and updated on October 24th, 2020."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger